The Unzyme Foundation, the philanthropic arm of Unzyme Laboratories, has announced a $50 million grant program to fund independent research into human enhancement technologies. The five-year initiative will support studies in areas critical to the responsible development and deployment of enhancement systems.
Program Overview
The Unzyme Laboratories Foundation Research Grant Program will award funding in three priority areas:
1. Enhancement Accessibility ($20M)
Studies examining barriers to enhancement access and potential solutions:
- Economic factors limiting access
- Geographic disparities in availability
- Strategies for expanding access to underserved populations
- Health system integration challenges
2. Long-Term Outcomes Research ($20M)
Longitudinal studies tracking enhancement recipients over extended periods:
- Physical health outcomes at 10+ years post-enhancement
- Psychological and social impacts
- Comparison studies with non-enhanced populations
- Identification of late-emerging effects
3. Ethical Frameworks ($10M)
Philosophical and policy research exploring:
- Consent frameworks for emerging technologies
- Justice considerations in enhancement distribution
- Enhancement in employment and competitive contexts
- Intergenerational implications
Independence Commitment
Grant recipients will maintain full academic freedom and ownership of all findings. The Foundation will not:
- Review or approve research findings before publication
- Restrict publication of negative or critical results
- Require any editorial input on conclusions
- Claim intellectual property rights to funded research
“Credible independent research requires genuine independence,” stated Foundation Director Dr. Amara Okonkwo. “We will fund studies that may challenge our practices—that’s precisely the point.”
Eligibility
Grants are available to:
- Accredited academic institutions
- Independent research organizations
- Qualified individual researchers with institutional affiliations
- Multidisciplinary research teams (encouraged)
Unzyme Laboratories employees and contractors are not eligible. Applicants must disclose any financial relationships with enhancement technology companies.
Application Process
The first funding cycle opens March 15, 2026. Interested researchers should submit preliminary proposals through the Foundation website. Full applications will be requested from selected preliminary applicants.
Review committees will include external bioethicists, patient advocates, and academics with no financial ties to the enhancement industry.
For eligibility requirements and application guidelines, visit the Unzyme Laboratories Foundation website (foundation.unzymelaboratories.com).